InnoCan Pharma Corporation

C$1.82As of Sun 8 Nov 2026, 12:00 UTC
CSE:INNOConsumer Staples
Country Canada
PE (Fwd) •••
TSR 7Y CAGR (28.37%)
Div yield —
ROE (11.81%)
Household & Personal Products
Beta (5Y) 0.42
PE TTM —
TSR TTM (90.16%)
Mkt cap C$8.638M
ROIC (127.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.28
25.49%
173.40%
Hold 7|8|6|4|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
12.45%
19.33%
24.08%
23.79%
Revenue$M
0.420
0.436
0.444
0.467
1.25%
6.07%
8.87%
14.16%
Peers (US$6.114M)
Cap (US$)
PE
1.202M
—
5.911M
10.26x
Capital
TTM
5Y
10Y
Leveragex
0.823
2.299
1.746
EBIT/Intx
2.343
0.132
0.133
Own earn%
(458.31)
(12.20)
(12.89)
Sh yield%
35.96
35.74
39.04
Owners
Insiders/Inst%
5.74
23.17
Short interest%
1.50
SBC / revenue%
4.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
1–5
$1 testx
—
Incr. ROIC%
3